Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,450 total articles

Genco Shipping & Trading Limited Responds to Diana Shipping Extending its Inadequate $24.80 Unsolicited Tender Offer

Genco Shipping & Trading Limited Responds to Diana Shipping Extending its Inadequate $24.80 Unsolicited Tender Offer

Genco Shipping & Trading Limited, a US-based drybulk shipowner, responded critically to Diana Shipping's extended $24.80 per share unsolicited tender offer, labeling it inadequate and below the company's net asset value. Genco’s Board recommends shareholders reject the offer to preserve upside potential. The company highlights its comprehensive val…

Portillo's and Vienna Beef Celebrate America’s 250th Anniversary with the Debut of a New Hot Dog That Turns Up the Heat on an American Classic

Portillo's and Vienna Beef Celebrate America’s 250th Anniversary with the Debut of a New Hot Dog That Turns Up the Heat on an American Classic

Portillo's, a Nasdaq-listed US restaurant chain, partners with Vienna Beef to introduce the limited-time Char'diniera Dog, a new hot dog featuring char-grilled beef, giardiniera, and provolone cheese, timed to America's 250th anniversary. This launch kicks off their Hot Dog Season celebration, alongside special patriotic packaging and loyalty progr…

Giftify’s CardCash Launches Campus Gift Card Exchange Program With Follett Higher Education Campus Bookstores

Giftify’s CardCash Launches Campus Gift Card Exchange Program With Follett Higher Education Campus Bookstores

Giftify, Inc., through its CardCash platform, announced a partnership with Follett Higher Education to establish gift card exchange services at around 700 campus bookstore locations nationwide, including major universities like Stanford and University of Texas. This new program aims to provide students and families with convenient access to convert…

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Emergent BioSolutions has secured a $52.7 million contract modification from the U.S. Department of Health and Human Services to supply its ACAM2000® smallpox and mpox vaccine and related materials. This contract supports biodefense preparedness, emphasizing the U.S. government's commitment to counter potential bioterror threats. Deliveries are sch…

Bit Origin Acquires NVIDIA Blackwell B300 AI Infrastructure with Contracted Customer Deployment in Malaysia

Bit Origin Acquires NVIDIA Blackwell B300 AI Infrastructure with Contracted Customer Deployment in Malaysia

Bit Origin Ltd acquires 16 NVIDIA Blackwell B300 AI servers totaling approximately $11 million in assets, expected to be deployed in Malaysia in Q3 2026 under existing customer and hosting contracts. This acquisition marks Bit Origin's strategic expansion into AI computing infrastructure, aimed at generating approximately $360,000 in monthly recurr…

Tenable Achieves FedRAMP High and Impact Level 5 Authorization

Tenable Achieves FedRAMP High and Impact Level 5 Authorization

Tenable Holdings, Inc. announced that its Tenable One Cloud Exposure product has achieved FedRAMP High and Impact Level 5 authorization, one of the most stringent U.S. government security certifications. This milestone allows the company to expand its support for highly sensitive federal environments, including the Department of War and intelligenc…

AvePoint Research Reveals AI Visibility Gaps Have Nearly Tripled as AI Agents Scale and Almost Half of Enterprise Employees Now Rely on Agents Daily or Weekly

AvePoint Research Reveals AI Visibility Gaps Have Nearly Tripled as AI Agents Scale and Almost Half of Enterprise Employees Now Rely on Agents Daily or Weekly

AvePoint's latest State of AI Report reveals that nearly half of enterprise employees now rely on AI agents weekly or daily, yet visibility gaps into unsanctioned AI tool usage have nearly tripled since 2025. Despite high organizational confidence in preventing unauthorized AI data access, security breaches have increased, causing delays in AI depl…

Beyond Meat® Launches Beyond Steak® Filet at Wegmans and H-E-B

Beyond Meat® Launches Beyond Steak® Filet at Wegmans and H-E-B

Beyond Meat, Inc. (NASDAQ: BYND) announces the retail debut of its new product, Beyond Steak Filet, at Wegmans and H-E-B following a successful direct-to-consumer launch where it became the top-selling product. The plant-based steak filet features 28g of plant protein, uses novel ingredients like mycelium and avocado oil, offers a clean label, and …

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi Health Corp., a Nasdaq-listed pharmaceutical company, announced the successful completion of its third commercial shipment of 5mg psilocybin capsules to Australia. The capsules are prescribed under Australia's Authorized Prescriber Scheme for treatment-resistant depression (TRD), with wider patient access and reimbursement through public and…

Creative Realities Announces Pricing of $12 Million Public Offering

Creative Realities Announces Pricing of $12 Million Public Offering

Creative Realities, Inc., a provider of digital signage and AdTech solutions, priced an underwritten public offering to raise approximately $12 million. The company plans to use the proceeds for working capital, debt paydown, general corporate purposes, and potential acquisitions. The offering includes shares of common stock and pre-funded warrants…

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Artelo Biosciences announced positive Phase 1 clinical trial results for ART26.12, their selective FABP5 inhibitor, demonstrating favorable safety, tolerability, and pharmacokinetics. Biomarker studies aided by AI identified potential indicators of target engagement, supporting further clinical development of ART26.12 for non-opioid treatment of ch…

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

Akari Therapeutics completed its previously announced private investment in public equity (PIPE) financing ahead of schedule, raising approximately $8.3 million in Q2 2026 including warrant exercises. The capital infusion strengthens the company's balance sheet as it prepares to advance its lead antibody drug conjugate (ADC) candidate, AKTX-101, in…

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

Polyrizon Ltd., a biotech company developing innovative intranasal hydrogels, has obtained central IRB approval to start its first human clinical trial testing NASARIX™, a nasal spray designed to block airborne allergens and manage seasonal allergic rhinitis. This regulatory milestone facilitates the progress of the trial aimed at evaluating the ef…

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

Alaunos Therapeutics reported new preclinical results from a diet-induced obesity mouse study of their investigational oral small-molecule ALN1003. The data demonstrate significantly lower liver weight after adjusting for body fat percentage, consistent with earlier findings of improved liver markers, reduced liver injury enzymes, favorable adipose…

AIB Data Centers Added to Russell Microcap® Index

AIB Data Centers Added to Russell Microcap® Index

AIB Data Centers Inc., focused on AI and HPC digital infrastructure, has been added to the Russell Microcap® Index as of June 29, 2026. This inclusion follows the company's recent name change and a successful $63.25 million public offering, enhancing its visibility among institutional investors as it expands its AI data center ecosystem.

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

Palisade Bio announced FDA clearance of the Investigational New Drug application for PALI-2108, enabling the start of a global Phase 2 clinical trial (ASCENTRA-UC) for treating moderately to severely active ulcerative colitis. The trial plans to enroll up to 204 patients across North America and Europe, with patient enrollment anticipated in late 2…